Lv2
108 积分 2022-05-30 加入
MAT2A Inhibition Blocks the Growth of MTAP-Deleted Cancer Cells by Reducing PRMT5-Dependent mRNA Splicing and Inducing DNA Damage
1个月前
已完结
TNG462 is a potential best-in-class MTA-cooperative PRMT5 inhibitor for the treatment of peripheral MTAP-deleted solid tumors
2个月前
已完结
Update on pediatric soft tissue sarcomas
2个月前
已完结
Phase Ib and dose-expansion study of GSK3326595, a PRMT5 inhibitor as monotherapy and in combination with pembrolizumab in patients with advanced cancers
3个月前
已完结
MTAP as an emerging biomarker in thoracic malignancies
3个月前
已完结
Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry
3个月前
已完结
Soft tissue sarcoma in Asia
4个月前
已完结
Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis
5个月前
已完结
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
5个月前
已完结
Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma
5个月前
已完结
皖公网安备34019202002308
